Why corticosteroids are used in the treatment of mycoplasma pneumonia

The use of hormones in the treatment of mycoplasma pneumonia is generally aimed at patients with severe disease and complications, which can reduce inflammation, relieve symptoms, and shorten the course of the disease.

Mycoplasma pneumonia is an acute lung inflammation caused by Mycoplasma pneumoniae, which is mainly manifested as fatigue, headache, sore throat, muscle aches, obvious cough, mostly episodic dry cough, severe at night, and purulent sputum, persistent paroxysmal cough is a typical manifestation of mycoplasma pneumonia.

For mild cases of mycoplasma pneumonia, hormone therapy is generally not needed. However, if the patient is seriously ill, such as severe lung infection, atelectasis, lung abscess, respiratory failure and other complications, the doctor will use hormone therapy, such as prednisone, dexamethasone, etc., according to the specific situation.

Hormones can reduce inflammation, relieve symptoms, and help patients improve ventilation and promote recovery. However, the use of hormones needs to strictly grasp the indications and dosage, and avoid long-term and high-dose use, so as not to cause adverse reactions.

Patients with mycoplasma pneumonia also need macrolide antibiotics such as erythromycin, roxithromycin, azithromycin, etc., to control the infection.

Patients should strictly follow the doctor's instructions and do not self-medicate.